Wegovy
semaglutide
Familiar brands. Linked to official sources.
Choose a medication to read its FDA-approved uses, dose schedule, and safety information, with links to the official prescribing information.
Switch between weekly injections and daily oral options, or view the side-by-side comparison table.
semaglutide
tirzepatide
oral semaglutide
orforglipron
liraglutide
Review manufacturer information, starting doses, and titration schedules from official labeling.

semaglutide · once weekly, subcutaneous
FDA-approved to reduce excess body weight and maintain weight reduction long term · see label
FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

tirzepatide · once weekly, subcutaneous
FDA-approved to reduce excess body weight and maintain weight reduction long term · see label
FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

oral semaglutide · once daily (morning, empty stomach)
FDA-approved to reduce excess body weight and maintain weight reduction long term · see label
FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

orforglipron · once daily (with or without food)
FDA-approved to reduce excess body weight and maintain weight reduction long term · see label
FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

liraglutide · once daily, subcutaneous
Novo Nordisk says it is discontinuing Saxenda; last shipments to wholesalers in late January 2027.
FDA-approved to reduce excess body weight and maintain weight reduction long term · see label
FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.
Estimate your realistic out-of-pocket monthly expense and determine manufacturer copay card eligibility rules.
Selected: Zepbound (Tirzepatide weekly injection). List price before insurance or coupons: ~$1,060 / 28-day supply.
Your commercial insurance plan covers anti-obesity medications on its formulary.
PA requirement notes: Approval typically requires documented BMI ≥30 or BMI ≥27 with at least one metabolic comorbidity, plus notes on prior lifestyle intervention attempts.
Transparency & Compliance Notice: Out-of-pocket estimates are educational benchmarks reflecting published manufacturer coupon guidelines, wholesale acquisition cost benchmarks, and commercial health plan rules as of 2026. TrimSoMo is an independent, non-commercial informational directory and has no financial affiliation with Novo Nordisk, Eli Lilly, or pharmacy benefit managers (PBMs). Final copays are determined solely by your employer contract, insurer deductible, and dispensing pharmacy.
You do not need to pick a brand here. A licensed clinician decides whether a medication is appropriate for you. Confirm costs and coverage directly with providers, pharmacies, or your insurer.